Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Leveljump Healthcare: Top 10 Undervalued Medical Diagnostics & Research Industry Stocks (JUMP)

AI-generated - The Globe and Mail - Mon Feb 19, 2024

Leveljump Healthcare is now ranked among the top 10 undervalued stocks in the Medical Diagnostics & Research industry on the Toronto Stock Exchange or TSX Venture Exchange.

  • A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company
  • Valuation methodology provided by Stockcalc (see below)

Medical Diagnostics & Research: Companies that provide laboratory testing services through imaging and other diagnostic services to the medical industry.

Stocks in this category are held primarily for capital appreciation.

SymbolNameClose Price ($)Valuation ($)DifferenceAverage Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
SZLSStageZero Life Sciences0.040.060.02 (40.9%)595464.90.00.0
ARCARCpoint0.120.150.03 (27.1%)1594110.30.00.0
TELOTelo Genomics0.150.170.02 (12.5%)4960911.10.00.0
JUMPLeveljump Healthcare0.080.090.01 (11.8%)155827.00.020.0

All data provided as of February 19, 2024.
The list is sorted by stocks with the greatest percentage difference between valuation and price.

Leveljump Healthcare

Leveljump Healthcare Corp is engaged in the business of providing radiology solutions for hospitals, emergency rooms, and private clinics. The company offers telehealth services that are designed to provide a doctor-to-doctor collaboration and diagnosis allowing effective patient care.

Leveljump Healthcare is listed under JUMP on the TSX Venture Exchange.

Stockcalc

StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs.

Stockcalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. Stockcalc’s Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including:

  • Discounted Cash Flow (DCF)
  • Price & Other Comparables
  • Multiples
  • Adjusted Book Value (ABV)
  • Analyst Consensus

Artificial Intelligence at Report on Business

Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.